Professional Documents
Culture Documents
CORPORATE FINANCE
INDUSTRY- BIOTECHNOLOGY
ROHIT SINGH
09PG101
1|Page
INDUSTRY-Biotechnology
Balance Sheet
2|Page
65 45 04 01 2 45 31 .28 .42 69 61
583. 511. 495. 477. 338. 300. 191. 119 112 50. 25.
Sundry Debtors 52 28 86 06 15 8 86 .34 .49 01 43
78.1 70.6 161. 175. 18.3 388. 10. 40. 14. 48.
Cash and Bank 1 6 07 53 468 6 45 64 72 8 19
611. 538. 333. 305. 170. 121. 112. 61. 48. 27. 24.
Loans and Advances 64 82 66 68 43 28 4 99 98 14 74
2,02 1,81 1,43 1,40 1,32 751. 1,00 433 352 160 148
Total Current Assets 3.92 5.21 1.63 5.28 0.78 89 0.02 .25 .61 .64 .97
Less : Current
Liabilities and
Provisions
496. 403. 371. 416. 325. 295. 180. 120 94. 24. 21.
Current Liabilities 88 08 94 21 62 74 3 .82 42 29 68
298. 281. 118. 173. 114. 30. 25. 13. 5.3
Provisions 4 66 25 83 64 79.1 60.5 29 94 2 1
Total Current 795. 684. 490. 590. 440. 374. 240. 151 120 37. 26.
Liabilities 28 74 19 04 26 84 8 .11 .36 49 99
1,22 1,13 941. 815. 880. 377. 759. 282 232 123 121
Net Current Assets 8.64 0.47 44 24 52 05 22 .14 .25 .15 .98
Miscellaneous
Expenses not written 21.2 21.1 27.0 27.1 31.7 28.9 26.2 14. 13. 4.0
off 5 1 3 4 3 7 9 59 33 2 3.4
54.2 52.5 14.6 2.9 2.2
Deferred Tax Assets 5 3 8.37 6 8.04 3.54 5.17 3 3 0 0
158. 138. 127. 107. 69.3 49.2 38.2 29. 21.
Deferred Tax Liability 68 89 6 12 6 8 5 93 13 0 0
- - - - - - - -
104. 86.3 119. 92.4 61.3 45.7 33.0 18.
Net Deferred Tax 43 6 23 6 2 4 8 -27 9 0 0
4,28 3,74 3,73 2,62 2,23 1,58 1,31 682 561 238 222
Total Assets 8.74 4.61 1.46 6.60 0.67 0.17 7.25 .75 .91 .9 .06
3|Page
Profit and Loss
4|Page
316. 231. 948. 591. 347. 328. 237. 144 118 63. 41.
Gross Profit 57 16 66 7 81 49 85 .31 .41 24 73
189. 166. 145. 114. 53.4 48.7 37.4 29. 19. 4.2
Depreciation 78 01 74 21 1 8 2 07 45 6.4 9
126. 65.1 802. 477. 294. 279. 200. 115 98. 56. 37.
Profit Before Tax 79 5 92 49 4 71 43 .24 96 84 44
110. 56.8 52.7 25.4 28.0 24. 21. 7.5
Tax 3.4 1.06 06 8 4 6 2 26 93 03 2
Fringe Benefit tax 5.47 4.89 5.23 3.87 3.56 0 0 0 0 0 0
- -
15.6 21.1 33.3 29.2 12.6 3.0 1.7
Deferred Tax 5 2 3 7 17.2 6 5.19 5 3 0 0
133. 80.3 654. 387. 220. 241. 167. 86. 72. 35. 29.
Reported Net Profit 57 2 3 47 9 59 22 19 3 81 92
- - -
119. 118. 263. - - - 0.1 0.0 1.6
Extraordinary Items 11 73 4 0.16 0.3 0.56 0.07 2 3 2 0
252. 199. 390. 387. 220. 242. 167. 86. 72. 34. 29.
Adjusted Net Profit 68 05 9 63 6 15 29 07 33 19 92
- - - -
- - 0.1 0.0 0.0 7.6
Adjst. below Net Profit 0.06 0 0.06 0 0 0 0 1 1 2 8
P & L Balance brought 1,28 1,13 826. 549. 301. 191. 119. 58. 18. 17.
forward 3.68 7.02 18 38 2 88 49 23 68 07 11
Statutory
Appropriations 0 0 0 0 0 0 0 0 0 0 0
94.5 93.8 136. 100. 70.2 81.5 108. 27. 32. 24. 16.
Appropriations 2 4 92 93 5 1 79 11 77 48 4
P & L Balance carried 1,32 1,12 1,34 835. 451. 351. 177. 117 58. 28. 16.
down 2.67 3.50 3.50 92 85 96 92 .2 2 38 84
63.7 63.7 61.4 38.7 33.6 31.4 17.4 8.6 11. 7.0 5.7
Dividend 8 8 1 9 6 7 8 8 66 4 1
0.6 0.7 0.9 0.8
Preference Dividend 0 0 0 2.04 4.07 4.39 0.82 6 7 3 2
5|Page
Calculations
2,36 2,00 2,25 2,17 1,51 1,27 995. 715. 584. 286. 220.
Sales Turnover 3.16 9.86 2.05 8.40 5.58 0.82 52 76 44 92 62
1,88 1,68 1,46 1,39 1,03 843. 666. 460. 401. 192. 159.
Variable Cost 4.21 3.97 4.07 9.84 9.76 79 87 78 59 11 10
478. 325. 787. 778. 475. 427. 328. 254. 182. 94.8 61.5
Contribution 95 89 98 56 82 03 65 98 85 1 2
Operating 1.20 1.08 0.79 1.22 1.27 1.21 1.25 1.51 1.31 1.23 1.19
Leverage 9195 2727 946 8982 3779 8832 2716 1978 0659 4827 1094
Financial 3.12 4.61 1.22 1.32 1.26 1.25 1.30 1.46 1.40 1.35 1.37
Leverage 3985 9954 7569 6729 8852 2583 8936 3381 9762 0809 9541
4,28 3,74 3,73 2,62 2,23 1,58 1,31 682. 561. 238. 222.
Total Liabilities 8.74 4.61 1.46 6.60 0.67 0.17 7.25 75 91 9 06
0.09 0.08 0.26 0.24 0.16 0.22 0.19 0.24 0.24 0.32 0.23
ROI 2356 038 4143 1186 7461 1723 9165 7001 8278 139 2595
133. 80.3 654. 387. 220. 241. 167. 86.1 35.8 29.9
PAT 57 2 3 47 9 59 22 9 72.3 1 2
Total
Shareholders 2,93 2,55 2,84 2,01 1,34 1,21 975. 420. 342. 155. 142.
Funds 3.02 9.16 0.21 7.21 2.13 2.16 68 67 73 96 69
0.03 0.02 0.17 0.14 0.09 0.15 0.12 0.12 0.12 0.14 0.13
ROE 1144 1449 5347 7518 9029 2889 6946 6239 8668 9895 4738
79.5 69.8 36.9 25.7 21.8 24.3 13.5
Interest 2 3 8 41.8 4 7 24.5 3 21.1 4 9.92
Total Loan 1,00 853. 579. 275. 330. 282. 268. 233. 168. 52.3 51.3
Fund 8.48 72 74 57 59 15 7 07 38 1 5
347. 331. 311. 333. 557. 85.8 72.8 29.0 30.6 28.0
24 73 51 82 95 6 7 1 50.8 3 2
Analysis:-
DOL:
The sensitivity of PBIT to changes in Unit sales is referred as the degree of operating leverage.
Looking at the Industry, it has high operating leverage this may be due to
Depreciation
6|Page
Salaries
Research and Development
Industry has high fixed cost, this may affect the EBIT in case when the Net Sales falls below, as
happens in times of recession, since company requires higher portion of income to meet its fixed
cost.
DOF
The sensitivity of PBT to change in PBIT is referred to as the degree of financial leverage. It
mainly considers the portion of Interest expense that the industry incurs. Higher the debt to
Equity ratio higher is the debt portion in the capital structure, higher debt results in paying higher
interest. This is good in times of boom as
Hence one could conclude that industry is having higher financial leverage, this may give rich
dividend in good times but could prove fatal during recession.
ROI
The ROI of the industry is low and is consistently going down over the past few years. Looking
at this and the average cost of debt one can say that the industry has not done well by not
employing more of debt in its capital structure. This had resulted in lower returns to the equity
shareholder’s & maximizes the overall cost of capital.
ROE
As the debt is less in the capital structure the industry in general has more number of share
holders. The control of the company is consolidated. The return to the equity share holder is low.
The industry is too dependent on the proposed growth in the sector, recession didn’t effect the
industry as the EBIT has a continuous growth over the years.
7|Page
BIOCON
BALANCE SHEET:
8|Page
334.6 264.7 544.1 137.1
Total Current Assets 777.01 525.07 511.65 5 7 5 5 95.83
Less : Current Liabilities and
Provisions
181.8 195.2 113.2
Current Liabilities 219.69 166.35 175.93 9 7 3 63.45 42.44
Provisions 76 68.16 40.66 40 33.08 14.28 2.58 5.66
221.8 228.3 127.5
Total Current Liabilities 295.69 234.51 216.59 9 5 1 66.03 48.1
112.7 416.6
Net Current Assets 481.32 290.56 295.06 6 36.42 4 71.12 47.73
Miscellaneous Expenses not
written off 0 0 0 0 0 0 0 0
Deferred Tax Assets 4.05 3.08 2.73 2.36 1.81 2.01 1.32 1.31
Deferred Tax Liability 45.09 42.91 42.49 30.34 23.78 19.68 15.62 11.34
- - - -
Net Deferred Tax -41.04 -39.83 -39.76 27.98 21.97 17.67 -14.3 10.03
1,538. 1,472. 1,048. 908. 772. 606. 195. 154.1
Total Assets 83 08 41 08 28 32 27 6
Contingent Liabilities 163.24 153.54 151.43 83.39 59.08 8.98 9 11.12
9|Page
Miscellaneous Expenses 109.19 29.58 11.04 7.33 0.55 6.3 2.54 1.3
Less: Pre-operative Expenses
Capitalised 0 0 0 0 0 0 0 0
659.6 463.6 366.8 203.3 126.6
Total Expenditure 822.7 691.33 8 534.9 7 6 6 7
236.8 186.1 209.2 163.7
Operating Profit 193.69 585.82 2 9 9 9 64.79 39.85
Interest 4.94 2.87 8.16 2.48 2.69 2.46 5.05 4.67
228.6 183.7 161.3
Gross Profit 188.75 582.95 6 1 206.6 3 59.74 35.18
Depreciation 74.28 69 57.61 22.85 18.09 13.85 12.02 7.78
171.0 160.8 188.5 147.4
Profit Before Tax 114.47 513.95 5 6 1 8 47.72 27.4
Tax 0 77.69 0 20.86 9.83 19.45 7.58 5
Fringe Benefit tax 1.45 1.27 0.92 0.51 0 0 0 0
Deferred Tax 1.22 0.07 11.78 6.01 4.29 3.36 4.27 2.09
158.3 133.4 174.3 124.6
Reported Net Profit 111.8 434.92 5 8 9 7 35.87 20.31
Extraordinary Items -91.04 261.25 0.03 0.17 0.18 0.05 0.12 0.01
158.3 133.3 174.2 124.6
Adjusted Net Profit 202.84 173.67 2 1 1 2 35.75 20.3
Adjst. below Net Profit 0 0 0 0 0 0 0 0
330.1 238.5 104.3
P & L Balance brought forward 770.5 437.56 4 2 7 59.07 23.2 2.89
Statutory Appropriations 0 0 0 0 0 0 0 0
Appropriations 81.38 101.98 50.93 41.86 40.24 79.37 0 0
437.5 330.1 238.5 104.3
P & L Balance carried down 800.92 770.5 6 4 2 7 59.07 23.2
Dividend 60 50 30 25 20 10 0 0
Preference Dividend 0 0 0 0 0 0 0 0
Equity Dividend % 60 100 60 50 40 20 0 0
194.9 111.5
Earnings Per Share-Unit Curr 5.08 42.64 15.33 13 17.16 12.34 5 9
Earnings Per Share(Adj)-Unit 194.9 111.5
Curr 5.08 42.64 15.33 13 17.16 12.34 5 9
678.2 469.8
Book Value-Unit Curr 68.7 132.73 94.05 80.18 69.45 54 6 9
CALCULATIONS
10 | P a g e
Funds 88 20
Debt 163.95 143.88 106.77 105.04 76.34 64.69 68.56 66.46
1,538. 1,472. 1,048.
Total Assets 83 08 41 908.08 772.28 606.32 195.27 154.16
1,016. 1,277.
Total Income 39 15 896.5 721.09 672.96 530.65 268.15 166.52
Total Expenditure 822.7 691.33 659.68 534.9 463.67 366.86 203.36 126.67
Employee Cost 80.09 68.31 58.57 31.98 32.95 33.21 28.76 18.22
Variable Cost 742.61 623.02 601.11 502.92 430.72 333.65 174.60 108.45
Contribution 273.78 654.13 295.39 218.17 242.24 197.00 93.55 58.07
less: Fixed Cost 80.09 68.31 58.57 31.98 32.95 33.21 28.76 18.22
Operating Profit 193.69 585.82 236.82 186.19 209.29 163.79 64.79 39.85
Interest 4.94 2.87 8.16 2.48 2.69 2.46 5.05 4.67
Gross Profit 188.75 582.95 228.66 183.71 206.60 161.33 59.74 35.18
Depreciation 74.28 69 57.61 22.85 18.09 13.85 12.02 7.78
Profit Before Tax 114.47 513.95 171.05 160.86 188.51 147.48 47.72 27.40
Reported Net Profit 111.8 434.92 158.35 133.48 174.39 124.67 35.87 20.31
Preference Dividend 0 0 0 0 0 0 0 0
Earnings Per Share 5.08 42.64 15.33 13 17.16 12.34 194.95 111.59
Degree of Operating 1.4134 1.1166 1.2473 1.1717 1.1574 1.2027 1.4438 1.4572
Leverage 96 06 19 6 37 6 96 15
Degree of Financial 1.6920 1.1398 1.3845 1.1574 1.1102 1.1105 1.3577 1.4543
Leverage 59 39 07 66 33 91 12 8
Degree of Total 2.3917 1.2727 1.7269 1.3562 1.2850 1.3357 1.9603 2.1193
Leverage 18 5 22 73 25 74 94 43
0.0726 0.2954 0.1510 0.1469 0.2258 0.2056 0.1836 0.1317
Return on Equity 53 46 38 91 12 17 94 46
0.1258 0.3979 0.2258 0.2050 0.2710 0.2701 0.3317 0.2584
Return on Investment 68 54 85 37 03 38 97 98
Analysis:
DOL
Biocon has a higher Degree of Operating leverage; this can be due to any of the above mentioned
reasons. This DOL also includes the weight added due to fixed cost and Biocon it seems has high
fixed cost.
Higher DOL will result in higher sensitivity of PBIT to changes in Unit sales; this may prove
fatal to industry during recession.
Hence company must try and take some make or buy decision, so as to minimize the DOL.
11 | P a g e
DOF:
Degree of Financial leverage of Biocon is much lower than the industry average. Hence one can
say company had employed lesser portion of debt in the capital structure. This on one hand had
resulted into:
But if one looks at it from the point of Modigliani & Miller we can say company belongs to
lower risk class.
The company had taken lower Debt in the past few years and must not be worried about
repaying it bacl instantly, the outlook of this sector is looking bright and one can very well
assume that the equity share holders of the company will be getting higher return.
ROI:
The company doesn’t have a good ROI and it has fallen consistently over the past few years, this
also tells about the non utilization of the assets. As the cost of debt is much less than the ROI
they had done well in using financial leverage but this should be maintained below a certain
range. Already discussed
ROE
The company has a bad return on equity and this is also due to the fact that the portion of equity
is more in the capital structure, the number of share holders is also more. Better control of the
organization. The debt to equity ratio is very low.
There is a continuous decrease in the EPS level of the company; the absence of debt in the
capital structure has resulted in higher number of equity share holder and thus the decrease.
DOL- is higher than the industry average this means that the company had higher amount
of fixed cost. This will be help full at times of recession. The company is doing more of
making than buying.
DFL- is also less than the industry, in the past few years the industry had suffered huge
losses and this had mainly resulted due to fall in sales because recession. The company is
better poised and as the outlook of the economy is changing they will make profit.
12 | P a g e
ROI- both the industry and the company is giving lesser return on the total assets. This is
one of the principle reasons why there is less of debt in their capital structure. The
company has a lesser ROI as compared to industry it means that it is not efficient in
utilizing its total assets.
ROE- the company has much more ROE as compared to the industry; the company is
efficiently utilizing the share holder’s fund and providing higher returns on it. There is
higher number of share holders and the optimal combination of debt and equity.
13 | P a g e
ALTERNATIVE 1: 25% with Preference shares @ 10% and 25% with debt
@ 10%
Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar
09 08 07 06 05 04 03 02 01 00
Share Capital 4.07 4.07 4.07 4.07 4.07 4.07 4.07 4.06 4.06 4.06
Interest 5.68 7.6 5.83 5.49 4.31 5.66 7.08 7.69 8.16 7.39
Total 59.7 50.62 44.23 40.35 39.73 38.72 38.04 37.28 39.41 39.56
Shareholders’
Funds
Debt 19.24 59.88 71.41 51.1 50.17 34.26 28.22 33.61 36.19 36.93
Total Assets 78.94 110.5 115.6 91.45 89.9 72.98 66.26 70.89 75.6 76.49
4
Extra Finance 39.47 55.25 57.82 45.72 44.95 36.49 33.13 35.44 37.8 38.24
5 5 5
Pref. Share @ 19.73 27.62 28.91 22.86 22.47 18.24 16.56 17.72 18.9 19.12
10% 5 5 25 5 5 5 25 25
Debt @ 15% 19.73 27.62 28.91 22.86 22.47 18.24 16.56 17.72 18.9 19.12
5 5 25 5 5 5 25 25
Total Income 906.7 898.5 838.6 735.0 610 487.1 432.4 427.3 382.1 354.3
6 4 9 4 4 7 2 9 3
Total 868.9 863.9 811.3 719.1 594.5 476.9 421.2 415.6 369.0 340.8
Expenditure 5 9 7 2 9 2 9 1 2
Employee Cost 35.06 28.61 22.56 17.13 13.55 11.37 9.94 10.04 9.22 7.84
Variable Cost 833.8 835.3 788.8 701.9 581.0 465.5 411.3 405.5 359.7 332.9
9 8 1 9 4 5 5 6 9 8
Contribution 72.87 63.16 49.88 33.05 28.96 21.59 21.12 21.76 22.40 21.35
less: Fixed Cost 35.06 28.61 22.56 17.13 13.55 11.37 9.94 10.04 9.22 7.84
Operating Profit 37.81 34.55 27.32 15.92 15.41 10.22 11.18 11.72 13.18 13.51
Interest 8.640 11.74 10.16 8.919 7.681 8.396 9.564 10.34 10.99 10.25
25 375 65 375 25 75 75 838 5 838
Gross Profit 29.17 22.81 17.15 7.00 7.73 1.82 1.62 1.37 2.19 3.25
Depreciation 8.71 7.57 5.41 3.4 8.22 2.5 2.84 2.99 4.2 4.23
Profit Before 20.46 15.24 11.74 3.60 -0.49 -0.68 -1.22 -1.62 -2.01 -0.98
Tax
Tax @ 35% 7.160 5.332 4.110 1.260 - - - - - -
912 687 225 219 0.171 0.236 0.428 0.566 0.705 0.342
94 86 66 43 25 43
Profit after Tax 13.30 9.90 7.63 2.34 -0.32 -0.44 -0.80 -1.05 -1.31 -0.64
Preference 1.973 2.762 2.891 2.286 2.247 1.824 1.656 1.772 1.89 1.912
Dividend 5 5 25 5 5 5 25 25
Equity Earnings 11.33 7.14 4.74 0.05 -2.57 -2.26 -2.45 -2.82 -3.20 -2.55
Degree of 1.927 1.828 1.825 2.076 1.879 2.112 1.889 1.856 1.699 1.580
14 | P a g e
Operating 268 075 769 005 299 524 088 655 545 311
Leverage
Degree of 1.848 2.267 2.326 4.421 - - - - - -
Financial 019 618 393 455 31.36 15.10 9.128 7.241 6.540 13.80
Leverage 9 16 39 83 94 86
Degree of Total 3.561 4.145 4.247 9.178 - - - - - -
Leverage 627 377 456 962 58.95 31.90 17.24 13.44 11.11 21.82
17 25 43 56 66 19
Return on Equity 0.112 0.059 0.044 0.017 - - - - - -
312 75 006 061 0.002 0.004 0.008 0.009 0.011 0.005
37 02 01 89 55 54
Return on 0.319 0.208 0.157 0.116 0.114 0.093 0.112 0.110 0.116 0.117
Investment 314 446 5 056 275 359 486 218 226 75
EPS 27.82 17.54 11.65 0.133 - - - - - -
638 561 178 062 6.306 5.563 6.026 6.956 7.881 6.276
66 61 01 14 16 34
15 | P a g e
Contribution 72.87 63.16 49.88 33.05 28.96 21.59 21.12 21.76 22.40 21.35
less: Fixed Cost 35.06 28.61 22.56 17.13 13.55 11.37 9.94 10.04 9.22 7.84
Operating 37.81 34.55 27.32 15.92 15.41 10.22 11.18 11.72 13.18 13.51
Profit
Interest 5.68 7.6 5.83 5.49 4.31 5.66 7.08 7.69 8.16 7.39
Gross Profit 32.13 26.95 21.49 10.43 11.10 4.56 4.10 4.03 5.02 6.12
Depreciation 8.71 7.57 5.41 3.4 8.22 2.5 2.84 2.99 4.2 4.23
Profit Before 23.42 19.38 16.08 7.03 2.88 2.06 1.26 1.04 0.82 1.89
Tax
Tax @ 35% 8.197 6.783 5.628 2.460 1.008 0.721 0.441 0.364 0.287 0.661
5 5
Profit after Tax 15.22 12.60 10.45 4.57 1.87 1.34 0.82 0.68 0.53 1.23
Preference 1.973 2.762 2.891 2.286 2.247 1.824 1.656 1.772 1.89 1.912
Dividend 5 5 25 5 5 5 25 25
Equity Earnings 13.25 9.83 7.56 2.28 -0.38 -0.49 -0.84 -1.10 -1.36 -0.68
Degree of 1.927 1.828 1.825 2.076 1.879 2.112 1.889 1.856 1.699 1.580
Operating 268 075 769 005 299 524 088 655 545 311
Leverage
Degree of 1.614 1.782 1.699 2.264 5.350 4.961 8.873 11.26 16.07 7.148
Financial 432 766 005 58 694 165 016 923 317 148
Leverage
Degree of Total 3.111 3.259 3.101 4.701 10.05 10.48 16.76 20.92 27.31 11.29
Leverage 443 03 99 28 556 058 19 308 707 63
Return on 0.128 0.076 0.060 0.033 0.013 0.012 0.008 0.006 0.004 0.010
Equity 562 256 311 882 232 24 357 7 707
Return on 0.319 0.208 0.157 0.116 0.114 0.093 0.112 0.110 0.116 0.117
Investment 314 446 5 056 275 359 486 218 226 75
Share Capital 79.43 78.24 73.14 63.21 62.20 56.96 54.60 55.00 58.31 58.68
5 5 25 5 5 5 25 25
EPS 1.667 1.256 1.033 0.361 - - - - - -
968 885 771 202 0.060 0.085 0.153 0.199 0.232 0.116
36 23 37 31 72 52
16 | P a g e
No of New
Equity Share
Issued
Year Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar
09 08 07 06 05 04 03 02 01 00
Interest 5.68 7.6 5.83 5.49 4.31 5.66 7.08 7.69 8.16 7.39
Total 59.7 50.62 44.23 40.35 39.73 38.72 38.04 37.28 39.41 39.56
Shareholders
Funds
Debt 19.24 59.88 71.41 51.1 50.17 34.26 28.22 33.61 36.19 36.93
Total Assets 78.94 110.5 115.6 91.45 89.9 72.98 66.26 70.89 75.6 76.49
4
Extra Finance 39.47 55.25 57.82 45.72 44.95 36.49 33.13 35.44 37.8 38.24
5 5 5
Equity Share 26.31 36.83 38.54 30.48 29.96 24.32 22.08 23.63 25.2 25.49
@50% Premium 333 333 667 333 667 667 667 667
Total Income 906.7 898.5 838.6 735.0 610 487.1 432.4 427.3 382.1 354.3
6 4 9 4 4 7 2 9 3
Total 868.9 863.9 811.3 719.1 594.5 476.9 421.2 415.6 369.0 340.8
Expenditure 5 9 7 2 9 2 9 1 2
Employee Cost 35.06 28.61 22.56 17.13 13.55 11.37 9.94 10.04 9.22 7.84
Variable Cost 833.8 835.3 788.8 701.9 581.0 465.5 411.3 405.5 359.7 332.9
9 8 1 9 4 5 5 6 9 8
Contribution 72.87 63.16 49.88 33.05 28.96 21.59 21.12 21.76 22.40 21.35
less: Fixed Cost 35.06 28.61 22.56 17.13 13.55 11.37 9.94 10.04 9.22 7.84
Operating Profit 37.81 34.55 27.32 15.92 15.41 10.22 11.18 11.72 13.18 13.51
Interest 5.68 7.6 5.83 5.49 4.31 5.66 7.08 7.69 8.16 7.39
Gross Profit 32.13 26.95 21.49 10.43 11.10 4.56 4.10 4.03 5.02 6.12
Depreciation 8.71 7.57 5.41 3.4 8.22 2.5 2.84 2.99 4.2 4.23
Profit Before 23.42 19.38 16.08 7.03 2.88 2.06 1.26 1.04 0.82 1.89
Tax
Tax @ 35% 8.197 6.783 5.628 2.460 1.008 0.721 0.441 0.364 0.287 0.661
5 5
Profit after Tax 15.22 12.60 10.45 4.57 1.87 1.34 0.82 0.68 0.53 1.23
Preference 0 0 0 0 0 0 0 0 0 0
Dividend
Equity Earnings 15.22 12.60 10.45 4.57 1.87 1.34 0.82 0.68 0.53 1.23
Degree of 1.927 1.828 1.825 2.076 1.879 2.112 1.889 1.856 1.699 1.580
Operating 268 075 769 005 299 524 088 655 545 311
Leverage
Degree of 1.614 1.782 1.699 2.264 5.350 4.961 8.873 11.26 16.07 7.148
Financial 432 766 005 58 694 165 016 923 317 148
Leverage
Degree of Total 3.111 3.259 3.101 4.701 10.05 10.48 16.76 20.92 27.31 11.29
Leverage 443 03 99 28 556 058 19 308 707 63
17 | P a g e
Return on Equity 0.128 0.076 0.060 0.033 0.013 0.012 0.008 0.006 0.004
0.010
562 256 311 882 232 24 357 7 707
Return on 0.319 0.208 0.157 0.116 0.114 0.093 0.112 0.110 0.116
0.117
Investment 314 446 5 056 275 359 486 218 226 75
Share Capital 86.01 87.45 82.77 70.83 69.69 63.04 60.12 60.91 64.61
65.05
333 333 667 333 667 667 667 667
EPS 1.769 1.440 1.262 0.645 0.268 0.212 0.136 0.110 0.082 0.188
842 425 675 106 592 382 212 983 495 835
YEAR 9-Mar
Sources OF Funds
No Of Shares 220078740
Amount to be doubled 3077.66
Case 1:
18 | P a g e
Equity 50% 769.415 No of Shares 2344003100
Preference 25% 384.7075 Tax Rate 35%
Debt 25% 384.7075 Preference Dividend 38.47075
Profit after Tax 36.90 Interest On Debt 57.706125
EPS 0.157423
Case 2:
Case 3:
Case 1:
EBIT 193.69
LESS: Interest 62.64613
EBT 131.04387
LESS: Tax @ 35% 45.8653545
PAT 85.1785155
LESS: Pref Dividend 38.47075
Equity Earnings 46.7077655
No Of Shares 2564081840
EPS 0.157423
Case 2:
EBIT 193.69
LESS: Interest 115.41225
EBT 78.27775
LESS: Tax @ 35% 27.3972125
PAT 50.8805375
19 | P a g e
LESS: Pref Dividend 38.47075
Equity Earnings 12.4097875
No Of Shares 3863644842
EPS 0.204223
Case 3:
EBIT 193.69
LESS: Interest 0
EBT 193.69
LESS: Tax @ 35% 67.7915
PAT 125.8985
LESS: Pref Dividend 0
Equity Earnings 125.8985
No Of Shares 2108015330
EPS 0.394134
Indifference Point
EBIT-12 41.47
EBIT-23 -32.44
EBIT-13 -16.01
Suggestion:
20 | P a g e
The leverage that the company will have would be similar in both the new as well as
the old capital structure.
Reference –capitaline.com
21 | P a g e